Heglems Pharmaceuticals Private Limited
About Heglems Pharmaceuticals Private Limited
Data last updated:
Heglems Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It was incorporated on 04 January 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2022PTC392016.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rakesh Kumar Mahto and Keerti Pandey.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No P – 50 T/F Block – P Vijay Vihar Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹46.59 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹18,349 (net margin 0.4%) and EBITDA of ₹26,379 (EBITDA margin 0.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U47721DL2022PTC392016, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U47721DL2022PTC392016 | Current |
| U85100DL2022PTC392016 | Previous |
| U72900DL2022PTC392016 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No P – 50 T/F Block – P Vijay Vihar Uttam Nagar, Delhi, India – 110059
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Heglems Pharmaceuticals Private Limited
The main business activity of Heglems Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Heglems Pharmaceuticals Private Limited FY 2024 filings available
Heglems Pharmaceuticals Private Limited reported revenue of ₹46.59 Lakh (up 212% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Heglems Pharmaceuticals Private Limited
Revenue rose 212% in the latest year. EBITDA fell 69% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Heglems Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹26,379 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18,349 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Heglems Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.6% | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Heglems Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Kumar Mahto | Director | 04 Jan 2022 | 4 Years 9 Months | Current |
| Keerti Pandey | Director | 18 Sep 2025 | 1 Years 1 Months | Current |
Peer Comparison of Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ruby Dental Private Limited | ₹47 Lakh (FY 2022) | •••• | •••• | 24.0% | •••• | Delhi, India |
| Fineall Pharmaceuticals Private Limited | ₹47 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Ocuris Pharmaceuticals Private Limited | ₹46.98 Lakh (FY 2021) | •••• | •••• | 12.0% | •••• | Gurgaon, Haryana, India |
| Mother Land Pharmaceuticals Private Limited | ₹46.68 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Kumbakonam, Tamil Nadu, India |
| Wellancia Pharmaceuticals Private Limited | ₹46.6 Lakh (FY 2025) | •••• | •••• | 503.0% | •••• | Palakkad, Kerala, India |
| Heglems Pharmaceuticals Private Limited this company | ₹46.59 Lakh (FY 2024) | •••• | •••• | 212.0% | •••• | Delhi, India |
| J M Active Devices Private Limited | ₹46.54 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Faridabad, Haryana, India |
| Shine Scientific International Private Limited | ₹46.5 Lakh (FY 2025) | •••• | •••• | 92.0% | •••• | Delhi, India |
| Edvenswa Pharmaceuticals Private Limited | ₹46.5 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Hyderabad, Telangana, India |
| Esan Pharmaceuticals Private Limited | ₹46.41 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | New Delhi, Delhi, India |
| Diatchi Pharmaceuticals Private Limited | ₹46.41 Lakh (FY 2016) | •••• | •••• | 168.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Heglems Pharmaceuticals by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Heglems Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Heglems Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Hemant Kumar Singh ceased to be Director on 18 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Heglems Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Heglems Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Heglems Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Heglems Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Heglems Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Heglems Pharmaceuticals Private Limited
Heglems Pharmaceuticals is an active private limited company based in Delhi, India. It was incorporated on 04 January 2022 (4+ years old) and is registered under CIN U47721DL2022PTC392016.
Heglems Pharmaceuticals reported revenue of ₹46.59 Lakh for FY 2024 (up 212% YoY).
Heglems Pharmaceuticals has 2 current directors:
- Rakesh Kumar Mahto - Director
- Keerti Pandey - Director
Heglems Pharmaceuticals reported a net profit of ₹18,349 (net margin 0.4%) and EBITDA of ₹26,379 (EBITDA margin 0.6%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Heglems Pharmaceuticals is U47721DL2022PTC392016. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Heglems Pharmaceuticals was incorporated on 04 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Heglems Pharmaceuticals by revenue are Ruby Dental Private Limited, Fineall Pharmaceuticals Private Limited, Ocuris Pharmaceuticals Private Limited, Mother Land Pharmaceuticals Private Limited, Wellancia Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals).
Hemant Kumar Singh ceased to be Director on 18 Sep 2025. Keerti Pandey was appointed as Director on 18 Sep 2025. Rakesh Kumar Mahto was appointed as Director on 04 Jan 2022.
The registered office of Heglems Pharmaceuticals is at Plot No P – 50 TF Block – P Vijay Vihar Uttam Nagar, Delhi, India – 110059.
Heglems Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.
No. Heglems Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.